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Abstract
Introduction: Mortality amongst COPD patients treated on the ICU is high. Health-related quality of life (HRQL)
after intensive care is a relevant concern for COPD patients, their families and providers of health care. Still, there
are few HRQL studies after intensive care of this patient group. Our hypothesis was that HRQL of COPD patients
treated on the ICU declines rapidly with time.
Methods: Fifty-one COPD patients (COPD-ICU group) with an ICU stay longer than 24 hours received a
questionnaire at 6, 12 and 24 months after discharge from ICU. HRQL was measured using two generic
instruments: the EuroQoL instrument (EQ-5D and EQ-VAS) and the Short Form 36 Health Survey (SF-36). The results
were compared to HRQL of two reference groups from the general population; an age- and sex-adjusted reference
population (Non-COPD reference) and a reference group with COPD (COPD reference).
Results: HRQL of the COPD-ICU group at 6 months after discharge from ICU was lower compared to the COPD
reference group: Median EQ-5D was 0.66 vs. 0.73, P = 0.08 and median EQ-VAS was 50 vs.55, P < 0.05. There were
no significant differences in the SF-36 dimensions between the COPD-ICU and COPD-reference groups, although
the difference in physical functioning (PF) approached statistical significance (P = 0.059). Patients in the COPD-ICU
group who were lost to follow-up after 6 months had low HRQL scores at 6 months. Scores for patients who died
were generally lower compared to patients who failed to respond to the questionnaire. The PF and social
functioning (SF) scores in those who died were significantly lower compared to patients with a complete follow
up. HRQL of patients in the COPD-ICU group that survived a complete 24 months follow up was low but stable
with no statistically significant decline from 6 to 24 months after ICU discharge. Their HRQL at 24 months was not
significantly different from HRQL in the COPD reference group.
Conclusions: HRQL in COPD survivors after intensive care was low but did not decline from 6 to 24 months after
discharge from ICU. Furthermore, HRQL at 24 months was similar to patients with COPD who had not received ICU
treatment.
Introduction
Survival after intensive care of patients with an acute
exacerbation of chronic obstructive pulmonary disease
(AECOPD) is poor. Almost 50% of patients die within
two years of admission [1-3]. Important considerations
for patients, their families and healthcare providers are
not only survival but also health-related quality of life
(HRQL) after intensive care [4]. There are only a few
published reports on HRQL after intensive care in
this group of patients [2,5]. In the COPD and Asthma
Outcome Study (CAOS), HRQL was assessed in 291
AECOPD patients 6 months after ICU care in the United
Kingdom using the EuroQoL 5-Dimension (EQ-5D) and
20-item Airways Questionnaire (AQ20) instruments [5].
These patients’ HRQL scores were significantly lower than
those in an age-matched general population, but similar to
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those of outpatients with COPD. Rivéra-Fernández and
coworkers followed HRQL for six years in fifty patients
with AECOPD at Spanish ICUs using a self-developed
validated instrument [6]. They found a nonsignificant
decline in HRQL scores in this selected cohort. These
results from the United Kingdom and Spain were surpris-
ing to us, given the facts that COPD is a progressive dis-
ease and HRQL in COPD deteriorates in tandem with
increasing disease severity and age [7]. Hence, the present
study was undertaken to examine the development of
HRQL from six months up to twenty-four months after
intensive care. We hypothesized that HRQL declines with
time in COPD patients after intensive care. We used the
EQ-5D instrument and the Short Form 36 Health Survey
(SF-36), both of which have been validated and are
commonly used in evaluating the critically ill patient
population [8-11]. The results were contrasted using mea-
surements of HRQL in two reference groups, one with
COPD and another without COPD, both derived from the
general population in the same region as the studied ICUs.
Materials and methods
In this prospective, longitudinal, multicentre study, we
recruited patients between August 2000 and July 2004
at three mixed medical-surgical ICUs in southeastern
Sweden. One is a university hospital and two are general
hospitals. Each ICU admits 500 to 750 patients annually.
Nearly all admissions to these three ICUs are emergen-
cies, and the most common primary diagnoses are mul-
tiple trauma, sepsis, and disturbances in the respiratory
or circulatory system or both. The Linköping University
Regional Ethics Review Board approved the study
protocol.
Patients ages 18 years and older who were admitted
to and remained in the ICU for more than 24 hours
(N = 1,663) were sent a letter inviting them to partici-
pate in a follow-up of their health. A set of structured
questionnaires was mailed to survivors, who had given
their consent to participate in the study, at six, twelve
and twenty-four months after discharge from the ICU.
Replies were initially received from 980 patients (59%).
Their mean age was 58.2 years, and 42% were female.
Selected results from this follow-up (LIVA Health-
related quality of life after intensive care in adults
Study) have been published previously [12].
We identified patients with COPD from among patients
with respiratory disease in the LIVA Study (COPD-ICU
group) by matching their data with information in the
Swedish Hospital Discharge Register and the Cause of
Death Register using the unique Swedish personal identity
number. Patients with primary codes from the Tenth
Revision of the International Classification of Diseases
(ICD-10) that were compatible with COPD (J44.0, J44.1,
J44.8 or J44.9) from hospital admission up to five years
before study start were included in the COPD-ICU group.
Patients who died within five years of the study start and
had a primary or secondary cause of death compatible
with COPD (ICD-10 codes cited above) on their death
certificates were also included in the COPD-ICU group.
Thus, 51 patients with COPD were identified using the
criteria described above. Their HRQL scores were fol-
lowed for 24 months after discharge from the ICU. Data
for loss of responders are shown in the study flowchart in
Figure 1. The clinical databases in each hospital were used
to extract data on age, sex, reason for admission, Acute
Physiology and Chronic Health Evaluation II (APACHE
II) score, ICU length of stay (LOS) and time in hospital,
time spent on ventilation and survival. We used the ICD-
10 codes of prior hospital admissions found in the Swedish
Hospital Discharge Register to compute the Charlson
comorbidity index (CCI) score [13].
To contrast HRQL measurements in the COPD-ICU
group, we used data from a public health survey per-
formed in the same geographic region. The survey was
mailed to 10,000 randomly selected individuals ages 20 to
74 years, from among whom 6,093 (61%) responded [14].
We formed a COPD reference group (N = 38) by match-
ing the personal identity numbers of survey responders
with information in the Swedish Hospital Discharge Regis-
ter and the Cause of Death Register using the same ICD-
10 codes as those used for the COPD-ICU group.
A non-COPD reference group (N = 51) was constructed
by calculating age- and sex-adjusted HRQL scores. These
HRQL scores were computed using coefficients that char-
acterized linear relationships between individual HRQL
domains, age and gender in the non-COPD responders of
the public health survey, Health and Health Related Qual-
ity of Life as measured by the EQ-5D and the SF-36 in
South East Sweden: Results from Two Population Surveys.
Vital status was ascertained from the Cause of Death Reg-
ister to analyze long-term survival.
Assessment of health-related quality of life
The instruments chosen for the evaluation of HRQL were
the EQ-5D and the SF-36 questionnaires [8,9]. Both are
internationally accepted and have been recommended
for measuring HRQL following critical care [10,15]. The
EQ-5D involves a health state classification scheme of five
items (mobility, self-care, usual activities, pain and/or dis-
comfort and anxiety and/or depression), each having three
alternatives [9]. Health states can be evaluated better than,
equal to or worse than death. For health states evaluated
as worse than death, the utility is negative [16]. The
answers in the first part range from 0 to 1. The second
part of the EQ-5D is a Visual Analogue Scale (EQ-VAS)
ranging from 0 (worst possible health state) to 100 (best
possible health state) on which the respondents rate how
they perceive their health status.
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The SF-36 instrument has 36 questions and generates
a health profile based on eight subscale scores: physical
functioning (PF), role limitations due to physical pro-
blems (RP), bodily pain (BP), general health (GH), vital-
ity (VT), social functioning (SF), role limitations due to
emotional problems (RE) and mental health (MH). The
scores on all subscales are transformed to a single scale
ranging from 0 (worst score) to 100 (best score) [17].
Statistics
HRQL data are presented as median values and inter-
quartile ranges because the measures are ordinal,
bounded by lower and upper limits, and the number of
observations is quite few. We also present mean values
as this is typically done with HRQL data.
Student’s t-test was used to compare groups at six
months if the Shapiro-Wilk test indicated that distributions
were normal; otherwise, the Wilcoxon rank-sum test was
used. The Friedman test was used to examine repeated
measurements in the same individual. A probability less
than 0.05 was considered statistically significant. No adjust-
ments were made for multiple testing in this study. The
statistical analysis was performed using Stata/SE version 12
software (Stata Corp, College Station, TX, USA).
Figure 1 Study outline. COPD, chronic obstructive pulmonary disease; HRQL, health-related quality of life; LOS, length of stay.
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Results
The patient characteristics were split into those who
were followed throughout the study and those who were
lost to follow-up (Table 1). Twenty patients (39%) did
not complete the study: nine died and eleven did not
respond to questionnaires at 12 or 24 months (see study
outline in Figure 1). Survival, which was followed for
two years longer than HRQL, was roughly 40% at
48 months (Figure 2).
Health-related quality of life
A detailed table with HRQL data is presented in the
Additional file.
The median EQ-5D scores at six months were 0.66
(interquartile range (IQR) = 0.26 to 0.76) in the COPD-
ICU group and 0.73 (IQR = 0.49 to 0.80) in the COPD
reference group (P = 0.08 for difference between groups).
The median EQ-VAS was 50 (IQR = 35 to 65) and 55
(IQR = 50 to 70) for the COPD-ICU and COPD reference
groups, respectively (P < 0.05 for difference). There were
no significant differences in the SF-36 dimensions between
the COPD-ICU and COPD reference groups, although the
difference in PF approached statistical significance (P =
0.059). Patients who were lost to follow-up after six
months had low HRQL scores at six months (Table 2).
The PF and SF scores of those who died were significantly
lower than patients with complete follow-up (Table 2).
Scores for patients who died were generally lower in all
dimensions compared to patients who failed to respond to
the questionnaire.
In patients with complete follow-up changes in HRQL
score over time were minor. The median EQ-5D score
was 0.66 at six months and remained unchanged at 12
and 24 months, whereas EQ-VAS scores were 51, 52 and
49 at 6, 12 and 24 months, respectively. Changes over
time in the SF-36 dimensions are shown in Figure 3.
Although always markedly lower than the non-COPD
reference group, SF-36 dimensions were not significantly
different from the COPD reference group with complete
longitudinal follow-up (Figure 3).
Discussion
There were three important findings in this prospective,
longitudinal, multicentre study. First, measures of HRQL
in COPD patients remained low but stable from six to
twenty-four months after discharge from the ICU. Thus,
we could not confirm our hypothesis of a decline in
HRQL in this cohort of chronically ill patients. Second,
HRQL in the COPD-ICU patient cohort was not signifi-
cantly different from patients with COPD who had been
hospitalized but not treated in ICU, that is, the COPD
reference group. Third, HRQL among ICU patients who
responded at six months but subsequently died was poor.
Methodological issues
Before considering these findings, we need to discuss
some methodological issues. The optimal way of secur-
ing a COPD diagnosis would have been spirometry
prior to admission [18]. However, spirometry is often
lacking in critically ill COPD patients. Previous studies
have reported absence of spirometry in about 50% of
patients deemed to have an acute exacerbation of
COPD [19,20]. In the absence of spirometry, the diagno-
sis of COPD is typically based on the presence of clini-
cal signs [19]. We identified 51 COPD patients in a
cohort of 980 patients (5.2%) treated for more than 24
hours in the ICU. The higher-than-expected proportion
of COPD patients [3] was probably due to selection of
patients with an ICU stay longer than 24 hours in the
basic study cohort.
Roughly 40% of the COPD cohort who responded six
months after ICU discharge were dead at forty-eight
months. This finding supports the notion that ICU
patients with COPD have a poor long-term prognosis,
given that the mortality rate during the first six months
after discharge was similar to that reported in a prior
Swedish study (46%) [3]. The subgroup of patients who
died during the follow-up period had poor HRQL, stres-
sing the need to analyze survivors and nonsurvivors sepa-
rately when the evolution of HRQL over time is
examined.
Table 1 Characteristics of the chronic pulmonary obstructive disease cohorta
Characteristics Complete follow-up
(N = 31)
Dead or lost to complete follow-up, (N = 20)
Males/females 12/19 6/14
Mean age, years (± SD) 69.7 (8.7) 70.7 (9.0)
APACHE II score, mean (± SD) 19.5 (6.7) 21.4 (8.2)
Charlson comorbidity index,
mean (± SD)
3.7 (2.0) 4.2 (1.9)
Number of patients with invasive ventilator treatment (%) 13 (42%) 8 (40%)
Days in ICU, median (IQR) 2.2 (1.3 to 4.6) 2.0 (1.8 to 9.4)
Days in hospital, median (IQR) 10 (5 to 15) 13 (6.5 to 21)
aAPACHE II, Acute Physiology and Chronic Health Evaluation II; IQR, interquartile range.
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There are a number of disease-specific instruments for
measuring HRQL and functional status in COPD [21].
The CAOS study and the Spanish study by Rivéra-Fer-
nández et al. [2,5] employed such instruments. We
chose to examine HRQL using generic instruments that
are regularly employed in patients following intensive
care [10]. The validity of the SF-36 has been shown
repeatedly. SF-36 scores have been shown to reflect
Figure 2 Long-term survival in the chronic obstructive pulmonary disease ICU group. Information on vital status was available for all
patients.
Table 2 Results of health-related quality of life measurement at six months in patients who had complete follow-up at




Dead (n = 9) No reply (n = 11)
EQ-5D 0.66 (0.62 to 0.80)
0.62
-0.02 (-0.17 to 0.74)
0.22
0.55 (0.26 to 0.73)
0.51
EQ-VAS 50 (40 to 60)
51.1
39 (5 to 70)
36
60 (43 to 73)
55
PF 45 (25 to 65)
45.5
18 (3 to 33)*
21
35 (10 to 45)
34
RP 25 (0 to 75)
37.5
0 (0 to 25)
18
0 (0 to 33)
21
BP 47 (22 to 100)
53.6
22 (10 to 52)
35
41 (22 to 52)
46
GH 40 (25 to 52)
43.1
23 (10 to 40)
31
44 (30 to 67)
49
VT 45 (35 to 55)
47.0
30 (15 to 48)
34
50 (35 to 60)
50




50 (38 to 88)
57
RE 83 (0 to 100)
58.3
0 (0 to 42)
23
83 (0 to 100)
60
MH 68 (48 to 88)
66.0
58 (24 to 90)
56
72 (40 to 80)
60
aBP, bodily pain; EQ-5D, EuroQoL 5 Dimension; EQ-VAS, EuroQoL Visual Analogue Scale; GH, general health; MH, mental health; PF, physical functioning ; RE, role emotional;
RP, role physical; SF, social functioning; VT, vitality. Values are medians (interquartile ranges) and means. *P < 0.05 compared to patients with complete follow-up.
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spirometric staging of disease [7,22], the St George’s
Respiratory Questionnaire [7,23] and at least two dys-
pnea scales [23,24]. Furthermore, the test-retest reliabil-
ity of SF-36 in the intensive care population has been
shown to be good [25,26]. We also used the EQ-5D,
which has been recommended for evaluating ICU popu-
lations [10,15,27], to facilitate comparison with one of
the few studies in this area: the UK CAOS study [5].
Analysis and reporting of HRQL is challenging. The
EQ-5D and SF-36 measures provide composite scores
derived from complex calculations. The eight separate
SF-36 dimensions are based on 36 statements that yield
data with wide distributions. The large number of state-
ments typically lead to varying response frequencies,
which is partly accounted for by the calculation algo-
rithms. Parametric statistical methods are commonly
employed despite ordinal measurements. This practice
may lead to spurious findings [28]. Important and clini-
cally significant differences may be missed when data
are reported conventionally [29].
There is no consensus regarding when a difference in
an SF-36 domain represents a clinically important differ-
ence. Dowdy et al. [30] referred to a difference of five
points, but they also commented that a five-point differ-
ence could have different implications for different
dimensions. Wyrwich et al. [31] suggested that a differ-
ence ranging from three to twelve points, varying with
dimension, is clinically important in COPD patients.
SF-36 scores in the current study were occasionally low
and had wide ranges, indicating significant floor and ceil-
ing effects for some dimensions [17]. This is a known
problem in the first version of SF-36, which we used, and
is partly due to a limited number of questions and
answers generating coarse scales in these dimensions.
The wide distribution of data limits the possibility of
identifying statistically significant patterns when the
number of observations is limited, as is true of the cur-
rent study.
Health-related quality of life in chronic obstructive
pulmonary disease patients after ICU care
Responses given six months after discharge from the ICU
showed that patients lost to follow-up had lower HRQL
scores, as indicated by their generally lower scores com-
pared to those who completed the follow-up. These obser-
vations were similar whether assessed using the EQ-5D or
the SF-36 (Table 2). Patients who died during the follow-
up period had low HRQL scores compared to survivors
with complete longitudinal follow-up. This difference was
most obvious for the PF and SF dimensions, which is in
line with prior research. A decline in PF was reported in
patients with COPD, with a further decline in combination
with higher comorbidity [32]. In a mixed Dutch ICU
population, some aspects of HRQL recovered over six
months, but the decreases in PF and SF remained [33].
In patients with a complete longitudinal follow-up, we
found that HRQL was fairly stable from six to twenty-
four months after intensive care. Moreover, it was quite
similar to the COPD reference group who had not been
treated in the ICU.
There are few studies on the development of HRQL
over time in COPD patients after ICU care. In the CAOS
study, Wildman et al. [5] reported slightly greater values
for EQ-VAS at six months after ICU discharge compared
to our study. Rivéra-Fernández et al. studied AECOPD
patients after intensive care [2]. Mortality after discharge
Figure 3 Short Form 36 Health Survey measurements at 6, 12 and 24 months of patients in the chronic obstructive pulmonary
disease ICU group providing responses at all three time points. There were no statistically significant changes over time (analyzed using
Friedman’s test). The non-chronic obstructive pulmonary disease (non-COPD) and COPD reference groups are added for comparison. Values are
means.
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from the ICU was high, but they were able to find 50
patients (16.2% of the initial cohort) six years after inten-
sive care. They found a decline in HRQL scores, but
these scores were not significantly different from pread-
mission scores. Comparisons with our results, however,
are difficult because Rivéra-Fernández et al. used an
instrument developed within their research group.
HRQL in COPD patients is complex and dependent on
several factors, such as dyspnea, depression, anxiety and
exercise tolerance [21,34]. COPD reduces HRQL and
more so with progression of the disease [7]. Patients with
COPD and comorbidity experience further reductions in
HRQL, particularly in the physical dimensions [32]. The
COPD-ICU group in our study had a fairly high CCI
comorbidity score [13], indicating that they had signifi-
cant comorbid disease in addition to COPD. In ICU
patients, factors often assumed to be important for
HRQL after recovery, such as age, prolonged mechanical
ventilation and ICU LOS, have not been shown to be of
primary importance [35]. HRQL prior to ICU treatment
and preexisting disease have both been found to be more
relevant [12,30]. Surprisingly, in studies of COPD
patients who had long-term home ventilation, blood
gases and lung function were not shown to be related to
HRQL [36,37].
An important strength of the present study is that we
were able to follow HRQL at three time points. We also
compared the results regarding HRQL in two reference
groups: (1) an age- and sex-adjusted reference population
(non-COPD reference) and (2) a COPD reference group
from among the general patient population. A further
strength is that we had information on comorbidity and
illness severity at the time of ICU admission. Prior studies
have stressed the importance of comorbidity for HRQL in
COPD and ICU patients [12,32]. A weakness of this study,
common to much work in this area, is the lack of informa-
tion regarding premorbid HRQL and stage of COPD.
Conclusions
Awareness of HRQL after critical illness is important if
we are to avoid the notion that ICU treatment of COPD
patients is futile and a burden for the patient and to
society [38,39]. HRQL is difficult to forecast in critically
ill COPD patients who survive ICU care, because infor-
mation that is typically available, such as age, sex, ICU
LOS, severity of illness and lung function parameters, is
of limited value for predicting HRQL after recovery
[30,35-37].
The present study showed that HRQL in COPD survi-
vors after intensive care was lower than that in the gen-
eral population but quite stable, and that it did not
decline from six to twenty-four months after discharge
from the ICU. HRQL at 24 months was similar to that
of patients with COPD who had not received ICU
treatment.
Key messages
• HRQL in COPD patients treated in the ICU was
low but did not decline further from six to twenty-
four months after ICU discharge.
• HRQL in COPD patients 24 months after dis-
charge from ICU was quite similar to that of COPD
patients not treated in the ICU.
Additional material
Additional file: The additional file table displays HRQL
measurements from all patients that provided responses at 6, 12
and 24 months after ICU discharge.
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